Innate immunity in inflammatory bowel disease: a disease hypothesis
Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent ev...
Gespeichert in:
Veröffentlicht in: | The Journal of pathology 2008-01, Vol.214 (2), p.260-266 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 266 |
---|---|
container_issue | 2 |
container_start_page | 260 |
container_title | The Journal of pathology |
container_volume | 214 |
creator | Marks, DJB Segal, AW |
description | Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. |
doi_str_mv | 10.1002/path.2291 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2635948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70190560</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</originalsourceid><addsrcrecordid>eNp1kE1v1DAQhq0KRJfCoX-g5ITEIa3HiZ2YQ6XVin7ACiq1VY-WP7tuk3ixs5T8e7LKUuCAZGkszTPPjF6EDgEfA8bkZC371TEhHPbQDDBnOa85e4FmY4_kRQnVPnqd0gPGmHNKX6F9qIFBVVYztLjsOtnbzLftpvP9kPlufK6RbSv7EIdMhSfbZMYnK5P9mMnf32w1rEO_ssmnN-ilk02yb3f1AN2efbpZXOTLb-eXi_ky17QEyGuoFSMlUaS0ijtpKLeaV0QpTohjwHVpwBlGgBhuHNNaGWqcYnWtneGkOECnk3e9Ua012nZ9lI1YR9_KOIggvfi30_mVuA8_BGEF5WU9Ct7vBDF839jUi9YnbZtGdjZskqgwcEwZHsEPE6hjSCla97wEsNhGLraRi23kI3v091V_yF3GI3AyAU--scP_TeJqfnOxU-bThE-9_fk8IeOjYFVRUXH39Vwsr_iXz9fVmViO_LuJdzIIeR99ErfXBEOBcV0STqH4BccwpkY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70190560</pqid></control><display><type>article</type><title>Innate immunity in inflammatory bowel disease: a disease hypothesis</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Marks, DJB ; Segal, AW</creator><creatorcontrib>Marks, DJB ; Segal, AW</creatorcontrib><description>Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</description><identifier>ISSN: 0022-3417</identifier><identifier>EISSN: 1096-9896</identifier><identifier>DOI: 10.1002/path.2291</identifier><identifier>PMID: 18161747</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Ltd</publisher><subject>Acute Disease ; bowel ; Crohn Disease - drug therapy ; Crohn Disease - genetics ; Crohn Disease - immunology ; Crohn's ; cytokine ; Gastrointestinal Agents - therapeutic use ; Genetic Predisposition to Disease ; Humans ; Immunity, Innate ; Invited Review ; macrophage ; neutrophil ; Neutrophils - immunology ; Nod2 Signaling Adaptor Protein - genetics ; Nod2 Signaling Adaptor Protein - physiology</subject><ispartof>The Journal of pathology, 2008-01, Vol.214 (2), p.260-266</ispartof><rights>Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</rights><rights>2007 Pathological Society of Great Britain and Ireland</rights><rights>Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. 2007</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</citedby><cites>FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpath.2291$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpath.2291$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,777,781,882,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18161747$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Marks, DJB</creatorcontrib><creatorcontrib>Segal, AW</creatorcontrib><title>Innate immunity in inflammatory bowel disease: a disease hypothesis</title><title>The Journal of pathology</title><addtitle>J. Pathol</addtitle><description>Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</description><subject>Acute Disease</subject><subject>bowel</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - genetics</subject><subject>Crohn Disease - immunology</subject><subject>Crohn's</subject><subject>cytokine</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Genetic Predisposition to Disease</subject><subject>Humans</subject><subject>Immunity, Innate</subject><subject>Invited Review</subject><subject>macrophage</subject><subject>neutrophil</subject><subject>Neutrophils - immunology</subject><subject>Nod2 Signaling Adaptor Protein - genetics</subject><subject>Nod2 Signaling Adaptor Protein - physiology</subject><issn>0022-3417</issn><issn>1096-9896</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1v1DAQhq0KRJfCoX-g5ITEIa3HiZ2YQ6XVin7ACiq1VY-WP7tuk3ixs5T8e7LKUuCAZGkszTPPjF6EDgEfA8bkZC371TEhHPbQDDBnOa85e4FmY4_kRQnVPnqd0gPGmHNKX6F9qIFBVVYztLjsOtnbzLftpvP9kPlufK6RbSv7EIdMhSfbZMYnK5P9mMnf32w1rEO_ssmnN-ilk02yb3f1AN2efbpZXOTLb-eXi_ky17QEyGuoFSMlUaS0ijtpKLeaV0QpTohjwHVpwBlGgBhuHNNaGWqcYnWtneGkOECnk3e9Ua012nZ9lI1YR9_KOIggvfi30_mVuA8_BGEF5WU9Ct7vBDF839jUi9YnbZtGdjZskqgwcEwZHsEPE6hjSCla97wEsNhGLraRi23kI3v091V_yF3GI3AyAU--scP_TeJqfnOxU-bThE-9_fk8IeOjYFVRUXH39Vwsr_iXz9fVmViO_LuJdzIIeR99ErfXBEOBcV0STqH4BccwpkY</recordid><startdate>200801</startdate><enddate>200801</enddate><creator>Marks, DJB</creator><creator>Segal, AW</creator><general>John Wiley & Sons, Ltd</general><scope>FBQ</scope><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200801</creationdate><title>Innate immunity in inflammatory bowel disease: a disease hypothesis</title><author>Marks, DJB ; Segal, AW</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5411-818b6242b24eb9fad59ec972bb922f619c4d1fd6212d9df6ccbd5dfb688cfd923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acute Disease</topic><topic>bowel</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - genetics</topic><topic>Crohn Disease - immunology</topic><topic>Crohn's</topic><topic>cytokine</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Genetic Predisposition to Disease</topic><topic>Humans</topic><topic>Immunity, Innate</topic><topic>Invited Review</topic><topic>macrophage</topic><topic>neutrophil</topic><topic>Neutrophils - immunology</topic><topic>Nod2 Signaling Adaptor Protein - genetics</topic><topic>Nod2 Signaling Adaptor Protein - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marks, DJB</creatorcontrib><creatorcontrib>Segal, AW</creatorcontrib><collection>AGRIS</collection><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marks, DJB</au><au>Segal, AW</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Innate immunity in inflammatory bowel disease: a disease hypothesis</atitle><jtitle>The Journal of pathology</jtitle><addtitle>J. Pathol</addtitle><date>2008-01</date><risdate>2008</risdate><volume>214</volume><issue>2</issue><spage>260</spage><epage>266</epage><pages>260-266</pages><issn>0022-3417</issn><eissn>1096-9896</eissn><abstract>Crohn's disease arises from a defective interaction between the highly concentrated mass of bacteria in the gastrointestinal tract and the underlying tissues. It has generally been believed to result from an excessively exuberant inflammatory response or from 'autoimmunity'. Recent evidence has emerged that the problem is instead a failure of the way in which the body responds to the penetration of bacteria and other bowel contents through the intestinal mucosal barrier. Rather than Crohn's disease being caused by excessive inflammation, the primary mechanism is actually that of an immunodeficiency. Failure of inflammatory mediator production leads to insufficient recruitment of neutrophils, resulting in inadequate removal of bacteria and other debris. This impairment of acute inflammation can be compensated in some circumstances by signalling through NOD2. If not cleared, the foreign material in the bowel wall is taken up within macrophages, eliciting a granulomatous reaction and the local and systemic sequelae so characteristic of Crohn's disease. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley & Sons, Ltd</pub><pmid>18161747</pmid><doi>10.1002/path.2291</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3417 |
ispartof | The Journal of pathology, 2008-01, Vol.214 (2), p.260-266 |
issn | 0022-3417 1096-9896 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2635948 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Acute Disease bowel Crohn Disease - drug therapy Crohn Disease - genetics Crohn Disease - immunology Crohn's cytokine Gastrointestinal Agents - therapeutic use Genetic Predisposition to Disease Humans Immunity, Innate Invited Review macrophage neutrophil Neutrophils - immunology Nod2 Signaling Adaptor Protein - genetics Nod2 Signaling Adaptor Protein - physiology |
title | Innate immunity in inflammatory bowel disease: a disease hypothesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T06%3A36%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Innate%20immunity%20in%20inflammatory%20bowel%20disease:%20a%20disease%20hypothesis&rft.jtitle=The%20Journal%20of%20pathology&rft.au=Marks,%20DJB&rft.date=2008-01&rft.volume=214&rft.issue=2&rft.spage=260&rft.epage=266&rft.pages=260-266&rft.issn=0022-3417&rft.eissn=1096-9896&rft_id=info:doi/10.1002/path.2291&rft_dat=%3Cproquest_pubme%3E70190560%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70190560&rft_id=info:pmid/18161747&rfr_iscdi=true |